Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_assertion type Assertion NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_head.
- NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_assertion description "[The aim of the present study is to examine the relationship between dopamine D2-receptor gene (DRD2) polymorphisms (Taq1A, Taq1B, -141C Ins/Del) and the risk of extrapyramidal adverse effects (EPS), assessed according to the Drug-Induced Extra-Pyramidal Symptoms Scale (DIEPSS), or the maintenance dose of antipsychotics in schizophrenic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_provenance.
- NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_assertion evidence source_evidence_literature NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_provenance.
- NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_assertion SIO_000772 15966462 NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_provenance.
- NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_assertion wasDerivedFrom befree-20140225 NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_provenance.
- NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_assertion wasGeneratedBy ECO_0000203 NP678047.RAccOXNiiiP4sjQQp2IPs-LlLn1__kte0nNCpWq9J9spg130_provenance.